BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+27.29%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.31B
AUM Growth
+$931M
(+17%)
Cap. Flow
-$8.53M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
41.19%
Holding
231
New
21
Increased
88
Reduced
44
Closed
16
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$74M |
| 2 |
Charles River Laboratories
CRL
|
$42M |
| 3 |
Abbott
ABT
|
$19.7M |
| 4 |
MTEM
Molecular Templates, Inc.
MTEM
|
$18.1M |
| 5 |
Arvinas
ARVN
|
$17.9M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$108M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$84.8M |
| 3 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$84.7M |
| 4 |
Gilead Sciences
GILD
|
$35.3M |
| 5 |
Teladoc Health
TDOC
|
$32.6M |
Sector Composition
| 1 | Healthcare | 95.59% |
| 2 | Industrials | 0.45% |
| 3 | Technology | 0.42% |
| 4 | Communication Services | 0.09% |
| 5 | Financials | 0.08% |